-
Contains�15�relevant, practice-oriented topics�including�special groups: ADHD+, such as mood/ dysregulation and disruptive behavior; SUD; autism; tics,�Tourette�syndrome, and�anxiety; sleep; cardiovascular; college-aged; transitional-aged youth; adults; and more.�
-
Provides in-depth�clinical reviews on�pharmacologic strategies in ADHD,�offering�actionable insights for clinical practice.�
-
Presents the�latest information on this timely, focused topic�under the leadership of experienced editors in the field.�Authors synthesize and distill the latest research and practice guidelines to create�clinically significant,�topic-based reviews.�
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
From Structural Disparities to Neuropharmacology: A Review of Adult Attention>Deficit/Hyperactivity Disorder Medication TreatmeMeasurement Informed Care in Attention-Deficit/Hyperactivity Disorder
Stimulants
The Pharmacokinetics and Pharmacogenomics of Psychostimulants
Nonstimulant Treatments for ADHD
Cardiovascular Considerations for Stimulant Class Medications
Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder in Individuals with Autism Spectrum Disorder
Pharmacologic Treatment of Comorbid Attention-Deficit/Hyperactivity Disorder and Tourette and Tic Disorders
Updates in Pharmacologic Strategies for Emotional Dysregulation in Attention Deficit Hyperactivity Disorder
ADHD Medications and Sleep
ADHD and Substance Use Disorders in Young People: Considerations for Evaluation, Diagnosis, and Pharmacotherapy
Addressing the Treatment and Service Needs of Young Adults with Attention Deficit Hyperactivity Disorder
Updates in Pharmacologic Strategies in Adult Attention-Deficit/Hyperactivity Disorder
A Review of Clinical Practice Guidelines in the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder
Authors
Jeffrey H. Newcorn Professor of Psychiatry and Pediatrics, Director, Division of ADHD and Learning Disorders, Icahn School of Medicine at Mount Sinai, Director, Pediatric Psychopharmacology, Mount Sinai Health System. Timothy E. Wilens Chief of the Division of Child and Adolescent Psychiatry and Co-director of the Center for Addiction Medicine; Massachusetts General Hospital (MGH); MGH Trustees Chair in Addiction Medicine and Professor of Psychiatry, Harvard Medical School.Dr. Timothy Wilens is Chief of the Division of Child and Adolescent Psychiatry and is Co-director of the Center for Addiction Medicine at Massachusetts General Hospital (MGH). He is the MGH Trustees Chair in Addiction Medicine and Professor of Psychiatry at Harvard Medical School (HMS). Dr. Wilens earned his MD at the University of Michigan Medical School in Ann Arbor and completed his residency in child, adolescent, and adult psychiatry at the MGH. Dr. Wilens' research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders; embedded health care models; and the pharmacotherapy of ADHD across the lifespan. He has published more than 350 peer-reviewed articles concerning these and related topics. He has also co-edited more than 90 book chapters, 5 books, and 350 abstracts and presentations for national and international scientific meetings. Dr. Wilens is a distinguished fellow of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry and serves on the board or as a scientific reviewer for more than 35 journals.
